Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study

There has been extensive debate about both the necessity of orthogonal confirmation of next-generation sequencing (NGS) results in Clinical Laboratory Improvement Amendments–approved laboratories and return of research NGS results to participants enrolled in research studies. In eMERGE-PGx, subjects...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Mol Diagn
Auteurs principaux: Rasmussen-Torvik, Laura J., Almoguera, Berta, Doheny, Kimberly F., Freimuth, Robert R., Gordon, Adam S., Hakonarson, Hakon, Hawkins, Jared B., Husami, Ammar, Ivacic, Lynn C., Kullo, Iftikhar J., Linderman, Michael D., Manolio, Teri A., Obeng, Aniwaa Owusu, Pellegrino, Renata, Prows, Cynthia A., Ritchie, Marylyn D., Smith, Maureen E., Stallings, Sarah C., Wolf, Wendy A., Zhang, Kejian, Scott, Stuart A.
Format: Artigo
Langue:Inglês
Publié: American Society for Investigative Pathology 2017
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500823/
https://ncbi.nlm.nih.gov/pubmed/28502727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2017.04.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires